Treatment of hormone receptor-positive BC cell lines with proliferation-promoting progestins increased Ser181-phosphorylation of PGRMC1 and its interaction with prohibitins, correlating with decreased binding of prohibitins to ERα and subsequent ERα activation, enabling the transcription of ERα-dependent genes and increasing proliferation [193]. Here, ESR1 is linked to breast cancer.